Lactate dehydrogenase and severity of pain in children with sickle cell Disease

Acta Haematologica

Volumn 126, Issue 3, 2011, Pages 157-162

  Najim, Oula Abdullah ^a   Hassan, Mea'Ad Kadhum ^a  

^a UNIVERSITY OF BASRAH   (Iraq)

Author keywords

Children; Lactate dehydrogenase; Pain; Sickle cell disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LACTATE DEHYDROGENASE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; BETA THALASSEMIA; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CHILD; CHILDHOOD DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; DYSURIA; FEVER; GENOTYPE; HUMAN; INFANT; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PAIN; PAIN ASSESSMENT; PALLOR; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD; SICKLE CELL ANEMIA; STEADY STATE; THORAX PAIN; VEIN OCCLUSION; VISUAL ANALOG SCALE;

ADOLESCENT; ANEMIA, SICKLE CELL; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; MALE; PAIN; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 79960496790     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000328416     Document Type: Article

References (23)

1. Balllas SK: Current issues in sickle cell pain and its management. Hematology 2007: 97-105.
2. Joshi M: Evaluation of pain. Indian J Anaesth 2006; 50: 335-339.
3. Dampier C, Setty BN, Eggleston B, Brodecki D, O'neal P, Stuart M: Vaso-occlusive in children with sickle cell disease: Clinical characteristics and biologic correlation. J Pediatr Hematol Oncol 2004; 26: 785-790. (Pubitemid 40019176)
4. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM, Gladwin MT: Lactate dehydrogenase as a biomarker of hemolysis - associated nitric oxide resistance, priapism leg ulceration, pulmonary hypertension and death in patient with sickle cell disease. Blood 2006; 107: 2279-2285. (Pubitemid 43345545)
5. Stuart J, Stone PC, Akinola NO, Gallimore JR, Pepys MB: Monitoring the acute phase responses to vaso-occlusive crisis in sickle cell disease. J Clin Pathol 1994; 47: 166-169. (Pubitemid 24095474)
6. Etienne-Julan M, Belloy MS, Decastel M, Dougaparsad Sl, Ravion S, Hardy-Dessources MD: Childhood sickle cell crises: Clinical severity, inflammatory markers and the role of interleukin-8. Haematologica 2004; 89: 863-864. (Pubitemid 38981348)
7. Isaacman DJ, Burke BL: Utility of serum Creactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med 2002; 156: 905-909. (Pubitemid 36343502)
8. La Gamma EF, De Castro MH: What is the rationale for the use of granulocyte and granulocyte macrophage colony-stimulating factors in the neonatal intensive care unit? Acta Pediatr Suppl 2002; 91: 109-116. (Pubitemid 35347070)
9. De Baun MR, Vichinsky E: Haemglobinobathies; in Behrman ER, Kliegman RM, Jenson HB (eds): Nelson's Textbook of Pediatrics, ed 18. Philadelphia, WB Saunders, 2007, pp 2025-2032.
10. Cohen LL, Lemanek K, Blount RL, Dahlquist LL, Lim CS, Palermo TM, McKenna KD, Weiss KE: Evidence-based assessment of pediatric pain. J Pediatr Psychol 2008; 33: 939-955.
11. Shapiro BS, Dinges DF, Carota-Ome E: Recording crisis pain in sickle cell disease; in Tyler DC, Krane EJ (eds): Advances in Pain Research and Therapy. New York, Raven Press, 1990, pp 313-321.
12. Gould D: Visual analogue scale (VAS). J Clin Nurs 2001; 10: 697-706.
13. Niederau C, Backmerhoff F, Schumacher B: Inflammatory mediators and acute phase protein in patient with Crohn's disease and ulcerative colitis. Hepatogastroenterology 1997; 44: 90-107. (Pubitemid 27096020)
14. Wall EJ: Childhood osteomyelitis and septic arthritis. Curr Opin Pediatr 1998; 10: 73-76. (Pubitemid 28151964)
15. Pesce MA: Reference range for laboratory tests and procedures; in Behrman ER, Kliegman RM, Jenson HB (eds): Nelson's Textbook of Pediatrics, ed 18. Philadelphia, WB Saunders, 2007, pp 2943-2954.
16. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN: Frequency of hemoglopinopathies and glucose 6 phosphate dehydrogenase in Basra. East Med Health J 2003; 9: 45-54. (Pubitemid 40520560)
17. Manik A, Amit A, Hemant K: Platelet distribution width (PDW) is increased in vaso-occlusive crises in sickle cell disease. Ann Hematol 2004; 83: 331-335.
18. Al Arrayed SS, Haites N: Features of sickle cell disease in Bahrain. East Med Health J 1995; 1: 112-119.
19. Graumlich SE, Powers SW, Byars KC, Schwarber LA, Mitchell MJ, kalinyak KA: Multidimensional assessment of pain in pediatric sickle cell disease. J Pediatric Psychology 2008; 26: 203-214.
20. Frei-Jones MJ, Baxter AL, Rogers ZR, Buchanan GR: Vaso-occlusive episodes in older children with sickle cell disease: Emergency department management and pain assessment. J Pediatr 2008; 152: 281-285.
21. Omoti CE: Hematological values in sickle cell anemia in steady state and during vasoocclusive crisis in Benin City, Nigeria. Ann African Med 2005; 4: 62-67. (Pubitemid 43136811)
22. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR: Prediction of adverse outcome in children with sickle cell disease. NEJM 2000; 342: 83-89. (Pubitemid 30036599)
23. Nduka N, Kazem Y, Saleh B: Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease. J Clin Pathol 1995; 48: 648-651.